BRAF as a therapeutic target: a patent review (2006 – 2012)

Author： Zambon Alfonso   Niculescu-Duvaz Dan   Niculescu-Duvaz Ion   Marais Richard   Springer Caroline J  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.2, 2013-02, pp. : 155-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benzodiazepine receptor ligands: a patent review (2006 - 2012)

By Guerrini Gabriella   Ciciani Giovanna  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 843-866

Informa Healthcare

Access to resources Recommend Favorite

BACE2 as a new diabetes target: a patent review (2010 – 2012)

By Southan Christopher  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 649-663

Informa Healthcare

Access to resources Recommend Favorite

Glycogen phosphorylase inhibition as a therapeutic target: a review of the recent patent literature

By Baker David J   Greenhaff Paul L   Timmons James A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 459-466

Informa Healthcare

Access to resources Recommend Favorite

Sulfonamides: a patent review (2008 – 2012)

By Carta Fabrizio   Scozzafava Andrea   Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 747-758

Informa Healthcare

Access to resources Recommend Favorite

Prostate cancer: therapeutic patent review

By Sepp-Lorenzino L.   Slovin S.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 12, 2000-12 ,pp. : 1833-1842

Informa Healthcare

Access to resources Recommend Favorite